Artificial Intelligence in Diagnostics Market Size, Share & Trends Analysis Report By Components (Software, Hardware, Services), By Diagnostics Type (Cardiology, Oncology, Pathology, Radiology, Chest and Lungs, Neurology) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Artificial Intelligence in Diagnostics Market Size & Growth Analysis

The global artificial intelligence in diagnostics market size was valued at USD 1.74 billion in 2025 and is projected to grow from USD 2.30 billion in 2026 to USD 21.40 billion by 2034, registering a CAGR of 32.16% during the forecast period from 2026 to 2034. North America dominated the artificial intelligence in diagnostics market with a market share of 39.2% in 2025.

Market Segmentation

Components Insights

The global artificial intelligence in diagnostics market is bifurcated into hardware, software, and services. The software segment dominates the global market and is projected to exhibit a CAGR of 33.5% over the forecast period. One of the main forces pushing the sector forward is the rising need for AI-powered and cloud-based augmented diagnostics solutions, which aid in providing more diagnostics precision when evaluating medical images of a patient. Additionally, the ongoing pandemic of COVID-19 and the introduction of cutting-edge AI software in diagnostics involving multiple data sources, such as genomics and proteomics, MRI, CT, and patient data, are expected to drive the market.

• For instance, in February of 2018, John Snow Labs released their Natural Language Processing (NLP) package, which included deep learning models tailored to the healthcare industry. Programmers may use these models to build software that can comprehend medical documents. This has contributed to the expansion of AI software in healthcare by assisting professionals in analyzing and identifying high-risk patients, matching patients to clinical trials, alerting caregivers about patient safety, automating clinical coding and billing, and making significant clinical recommendations.

Request Customizationto receive a tailored report.

Diagnostics Type Insights

The artificial intelligence in diagnostics market is segmented into cardiology, oncology, pathology, radiology, chest and lungs, and neurology. The neurology segment owns the highest market share and is expected to grow at a CAGR of 31.4% during the forecast period. Growing older populations and rising rates of certain neurological conditions, including epilepsy, Alzheimer's disease, and Parkinson's disease, are boosting the need for accurate diagnoses and favorably affecting market expansion. According to the United Nations World Ageing Population 2017 study, there will be 2.1 billion individuals over 60 on the planet by the year 2050, double the 962 million there were in 2017.

Additionally, the use of value-based care is accelerating the segment's growth, a developing trend in managing the burden of neurological disorders. The development of sophisticated deep neural networks and cutting-edge algorithms trained on many image datasets acquired for various assessments and diagnoses are among the drivers driving this market's expansion. In addition, AI-based diagnostics options in neurology increase precision and accuracy as well as the productivity and clinical judgment of the radiologist. The widespread usage of AI-enabled solutions has aided the improvement of neurological departments.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America Market Trend

North America is the most significant global artificial intelligence in diagnostics market shareholder and is estimated to exhibit a CAGR of 32.5% over the forecast period. The presence of a well-established healthcare IT infrastructure, ongoing technological improvements, rising digital literacy, the creation of startups, supportive government initiatives, expanding funding opportunities, and significant players in the region were all credited with this expansion. In addition, the use of AI in diagnostics is accelerating due to the growing need for lowering testing costs, enhancing patient care, and decreasing machine downtime. According to Health IT Analytics, Case Western Reserve University researchers used a deep learning network, a type of AI, in May 2017 to correctly identify breast cancer in pathology photographs.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Market Insights

Europe is estimated to exhibit a CAGR of 32.2% over the forecast period. Due to several important reasons, including rising expenses, an aging population, rising prevalence of chronic illnesses, rising treatment demand, and a stagnant or declining healthcare workforce, the sustainability of the European healthcare sector is in danger. Additionally, structural inefficiencies in some European nations are a problem for the sector. The shift to value-based healthcare is anticipated to increase the need for improved patient outcomes at a more manageable price. In addition, AI integration into cutting-edge medical technologies can solve urgent healthcare problems.

Furthermore, many healthcare AI applications are in use or being deployed. These applications can help detect diseases early, improve diagnostics, discover new human physiology patterns, and create personalized diagnoses and treatments. For instance, in 2018, the GDPR created requirements for collecting, processing and securing personal data in healthcare organizations. This rule covers genetic, biometric, and health-related data. Similarly, in April 2019, the EU issued healthcare recommendations on moral AI for enterprises and governments. Privacy and Data Governance, Transparency, Technical Robustness and Safety, Non-discrimination, Diversity and Fairness, Accountability, Human Agency and Oversight, and Environmental and Societal well-being are the seven AI requirements. Such factors are anticipated to propel market growth over the forecast period.

Asia-Pacific Market Growth

Asia-Pacific is anticipated to register significant growth over the forecast period. AI-based diagnostics solutions are growing due to public and private initiatives. Startups, visibility, and investment boost regional industry growth. Private finance and startup incubators also affect regional market growth. Acute and chronic illnesses and an aging population are expected to boost market growth. In addition, the growing patient pool, pandemic, cloud computing, and government AI programs are expected to drive the Asia-Pacific market. AI is also used in diagnostics and by biopharmaceutical companies to modernize medication research. For instance, in 2017, Tencent launched AI Medical Innovation System (AIMIS), an AI-driven diagnostics medical imaging facility. The first lung and esophageal cancer diagnoses were 90% and 95% accurate, respectively.

Latin America Market Trends

Latin America is expected to be a potentially lucrative location for AI in the diagnostics industry due to politics, a shortage of skilled labor, and the government's openness to embracing current technologies. The International Development Research Centre (IDRC) and Oxford Insights evaluated the governments of 194 countries about their readiness to deploy AI, and Uruguay, Mexico, and Brazil were among the top 50. The regional market is expected to be driven by the expanding breadth of digitalization, the growth of IT infrastructure, technological improvements to improve patient care quality, and lower healthcare costs. For instance, Brazilian Minister Marcos Pontes launched eight AI laboratories in 2019, focusing on partnerships with funding and research support organizations. Industry 4.0, smart cities, health, and agribusiness were the focus areas for four of the eight laboratories.

In the Middle East and Africa (MEA), the demand for advanced healthcare facilities is anticipated to rise due to rising chronic illnesses like respiratory conditions, heart diseases, and an aging population. Chronic conditions like obesity, cardiovascular disease, and diabetes are becoming more common. This is due to several reasons, including sedentary lifestyles, hypertension, bad eating habits, physical inactivity, and inadequate sleep. The regional market is expanding quickly due to cooperation between the government, business stakeholders, and other investors in the healthcare ecosystem.

• For instance, Nigeria created a system called Apmis that enables healthcare experts, hospital owners, patients, and caregivers to share and exchange healthcare records. It makes data exchange visible, simple, safe, and affordable possible.

List of Key and Emerging Players in Artificial Intelligence in Diagnostics Market